Health Canada approves tirzepatide for chronic weight management in adults Eli Lilly anticipates that Zepbound (tirzepatide) will be available in the KwikPen format this summer. Deciding whether to re-dose when a child vomits after taking an oral medicationPediatrician, pharmacologist–pharmacist group outlines factors to consider and introduces a new decision support tool to help care providers make informed decisions. NEW PRODUCT: Pixxoscan Get the info you need on this new product, part of our drug news roundup for May. It’s time to dive into pharmacogenomics Here’s why pharmacists should lead the way in the emerging field of precision medicine. Breaking the cycle: Lamotrigine and hormonal contraceptive interactions A qualitative study found that 51% of women taking lamotrigine were unaware of the interaction with their COCs. NEW VACCINE: mResvia: first mRNA vaccine for RSV prevention Get the info you need on this new vaccine, part of our drug news roundup for May. Teva Canada brand birth control pills Seasonale tablets recalled for extra placebo pills The agency says the recall covers Seasonale Tablets made by Teva Canada with 0.03 milligrams of ethinylestradiol and 0.15 milligrams of levonorgestrel. NEW VACCINE: MenQuadfi, new quadrivalent conjugate meningococcal vaccine Get the info you need on this new vaccination, part of our drug news roundup for May. Free webinar: Promoting antimicrobial stewardship in rural locations The session will provide evidence-based advice to encourage appropriate antimicrobial use. Two new Health Canada advisories physicians and pharmacists should know about Get the info you need on these new drug-related Health Canada advisories, part of our drug news roundup for May. First Previous 10 11 12 13 14 Next Last
